.
MergerLinks Header Logo

New Deal


Announced

Telenor to acquire the rest of DNA shares through the tender offer.

Financials

Edit Data
Transaction Value£1,091m
Consideration TypeCash
Capital Owned54%
Capital Bid For40%
EV/Sales3.4x
EV/EBITDA11x
Share Price Premium7.4%
One Off Charge-

Tags

Edit

fixed & mobile telecommunications

Tender Offer

Acquisition

Mobile

Landline

Finland

Public

Friendly

Pending

Majority

Single Bidder

Private Equity

Synopsis

Edit

Telenor made mandatory public cash tender offer to acquire all of the issued and outstanding shares in DNA that are not held by DNA or any of its group companies or by the Offeror or any of its group companies for €20.90 ($23.50) per Share. The initially scheduled offer period of the Tender Offer expired on 26 September 2019. According to the final results of the Initial Offer Period of the Tender Offer, Telenor acquired 40% of all the shares in DNA. Now Telenor stakes represent 94% of all the shares in DNA. The settlement of the completion trades for the Initial Offer Period is expected to take place on 2 October 2019. “I am very pleased to announce today’s transaction and our entry into Finland, the fastest growing mobile market in Europe. DNA is an exciting addition to Telenor Group, and a natural complement to our existing operations in the Nordic region. Not only are we strengthening our footprint in the Nordic region, we are also gaining a solid position across fixed and mobile in the Finnish market and making room for further value creation." Sigve Brekke, Telenor Group Chief Executive.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US